GAMMA Investing
KZIA icon

GAMMA Investing’s Kazia Therapeutics KZIA Stock Holding History

GAMMA Investing’s Portfolio KZIA Stock Details KZIA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$21.7K Buy
2,264
+338
+18% +$4.24K ﹤0.01% 2904
2026
Q2 		$27.1K Buy
1,926
+358
+23% +$4.36K ﹤0.01% 2678
2026
Q1 		$11.7K Buy
1,568
+1,336
+576% +$9.3K ﹤0.01% 2991
2025
Q4 		$1.6K Buy
+232
New +$1.98K ﹤0.01% 3669
2025
Q3 		– Sell
-265
Closed -$1.66K – 3894
2025
Q2 		$1.66K Hold
265
– – ﹤0.01% 3439
2025
Q1 		$1.04K Buy
+265
New +$1.57K ﹤0.01% 3552

Other funds holding KZIA

Barclays
Barclays London, United Kingdom $500B AUM 36.84% 1-Year Est. Return
SteelPeak Wealth
SteelPeak Wealth Woodland Hills, California $4.07B AUM 38.25% 1-Year Est. Return
Westside Investment Management
Westside Investment Management Santa Monica, California $785M AUM 29.89% 1-Year Est. Return
Citigroup
Citigroup New York $308B AUM 40.94% 1-Year Est. Return
T3 Companies
T3 Companies New York $103M AUM 54.73% 1-Year Est. Return
ORG Wealth Partners
ORG Wealth Partners Dallas, Texas $607M AUM 23.88% 1-Year Est. Return
FNY Investment Advisers
FNY Investment Advisers New York $402M AUM 85.9% 1-Year Est. Return
Caitong International Asset Management
Caitong International Asset Management Hong Kong $1.04B AUM 150.25% 1-Year Est. Return
Allworth Financial
Allworth Financial Folsom, California $28.2B AUM 13.34% 1-Year Est. Return

GAMMA Investing's KZIA Position: Q3 2026 in Review

GAMMA Investing increased its Kazia Therapeutics (KZIA) stake by 18% in Q3 2026, buying an estimated $4.24K and bringing the position to 2,264 shares worth $21.7K. The position accounts for ﹤0.01% of the portfolio, ranked #2904.

GAMMA Investing first reported a position in KZIA in Q1 2025 and has held it in 6 quarters since. The position peaked at $27.1K in Q2 2026. 10 funds tracked by Wall St. Rank hold KZIA as of Q3 2026.

  • GAMMA Investing held 2,264 shares of Kazia Therapeutics worth $21.7K as of Q3 2026.
  • GAMMA Investing bought 338 Kazia Therapeutics shares in Q3 2026, an estimated $4.24K.
  • Kazia Therapeutics made up ﹤0.01% of GAMMA Investing's portfolio in Q3 2026, its #2904 holding.
  • GAMMA Investing first reported a position in Kazia Therapeutics in Q1 2025 and has held it in 6 quarters since.
  • GAMMA Investing's Kazia Therapeutics position peaked at $27.1K in Q2 2026.
  • 10 funds tracked by Wall St. Rank held Kazia Therapeutics as of Q3 2026.

Based on GAMMA Investing's 13F filing for Q3 2026, filed 8 Oct 2026.